Newsroom-Katalog
Zeit | Acousia Therapeutics GmbH: Meldungen vom 12.08.2024 |
---|---|
09:08 | Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences |
Zeit | Acousia Therapeutics GmbH: Meldungen vom 12.08.2024 |
---|---|
09:08 | Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences |